What's up in
Most modeling efforts during the COVID-19 pandemic have sought to address urgent practical concerns. But some groups aim to bolster the theoretical underpinnings of that work instead.
Researchers are tracking the different strains of SARS-CoV-2 and studying how they spread through our population and our bodies.
In the fight against COVID-19, disease modelers have struggled against misunderstanding and misuse of their work. They have also come to realize how unready the state of modeling was for this pandemic.
While the study of the SARS-CoV-2 virus was the most urgent priority, biologists also learned more about how brains process information, how to define individuality and why sleep deprivation kills.
An unorthodox symbiotic theory about the origin of eukaryotes’ defining characteristic may soon be put to the test.
Emmanuelle Charpentier and Jennifer Doudna have been awarded the 2020 Nobel Prize in Chemistry for their development of CRISPR/Cas9 genetic editing.
Harvey Alter, Michael Houghton and Charles Rice were awarded the 2020 Nobel Prize in Physiology or Medicine for their discovery of the cause of a major liver disease.
Studies suggest that self-disseminating vaccines could prevent the “spillover” of animal viruses into humans as pandemic diseases.
Researchers are examining the power of subtle genetic weaknesses in the immune system to affect the severity of infectious diseases, including COVID-19.